Halozyme Therapeutics, Inc. (HALO) NASDAQ
66.28
-1.86(-2.73%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
66.28
-1.86(-2.73%)
Currency In USD
| Market Cap | 8.07B |
| Enterprise Value | 10.07B |
| P/E Ratio | 22.45 |
| PEG Ratio | -0.93 |
| Price/Sales Ratio | 5.21 |
| Price/Book Ratio | 35.65 |
| Enterprise/Revenue | 6.43 |
| Enterprise/EBITDA | 10.09 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.23 |
| Operating Margin | 0.57 |
| Return On Assets | 0.13 |
| Return On Equity | 1.26 |
| Revenue | 1.4B |
| Revenue/Share | 12.77 |
| Gross Profit | 1.09B |
| EBITDA | 904.34M |
| Net Income | 316.89M |
| Diluted EPS | 2.56 |
| Total Cash | 318.62M |
| Total Cash/Share | 2.7 |
| Total Debt | 2.14B |
| Total Debt/Equity | 9.76 |
| Current Ratio | 2.76 |
| Book Value Per Share | 1.86 |
| 52-Week Change | 19.12 |
| 52-Week High | 82.22 |
| 52-Week Low | 51.06 |
| Moving Average 50 Days | 66.21 |
| Moving Average 200 Days | 69.24 |
| Average Volume | 1.61M |
| Shares Outstanding | 118.61M |
| % Held by Institutions | 100.26 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |